||EPS - Basic
||Market Cap (m)
|Pharmaceuticals & Biotechnology
York Pharma Share Discussion Threads
Showing 3151 to 3168 of 3175 messages
|You`ve prob lost quite a bit Topinfo with this dog and i`m sorry to hear hit.
I suggest you just move on, there`s no point beating yourself up about it.
Take the hit ,learn the lesson and you`ll be a better investor in the future.|
|If Richard Hughes is involved, then the business may well get re-listed at some point in the future.|
|And everyone lived happily ever after 'again', except for shareholder who have been shafted be the directors they paid to look after their interests.
How could they have done a deal so quickly unless it had been sorted out before the administration, and it gave no opportunity for third parties to create a competitive situation.|
|Hughes is owner of York Pharma
Richard Hughes, a Manchester-based investment banker, has emerged as the new owner of York Pharma, the Aimlisted drug company that collapsed last month leaving shareholders with nothing.
The company, which specialises in products for skin complaints such as psoriasis and acne, called in administrators after directors failed to pay back a $750,000 (£450,000) loan owed to US pharmaceuticals group Uluru.
Uluru lent York $1m in April ahead of a possible takeover. But Uluru pulled out of the talks in June and York's directors were able to repay only $250,000.
Hughes's investment vehicle RH Acquisitions bought the remaining debt from Uluru on July 27, the same day that York entered administration, and it is believed Hughes then took control of its assets in return for writing off the debt.
York Pharma was founded in 2003 and floated on Aim in 2004.
Debt-rescue rogues are targeted
The Government is planning to crack down on firms that boast they can get debts written off on a legal technicality.
The curbs were announced as the Ministry of Justice took action to close its 100th rogue company since it began policing the debt management sector in 2007.
The sector has ballooned recently, helping thousands of people to fight mis-selling cases against the banks. Typically, cases involve mortgage endowment policies, payment protection insurance and overdraft fees. But some companies use aggressive pressure-selling and cold-calling to win new customers, or claim they can have debts written off due to legal loopholes - claims that are unfounded.
Kevin Rousell, head of regulation at the Ministry of Justice, says: 'Most firms operate within the rules, but some flout those rules and target vulnerable consumers in debt. Some people pay big fees for a service that doesn't live up to the hype and that is the area we intend to tackle.'|
|History repeats itself:
|ulu got their money back:
ULURU Inc. Announces Status of York Note Receivable
ADDISON, Texas, July 27 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) ("the Company") today announced that it has collected $1,024,544 which represents all of the accrued and unpaid principal and interest associated with the Promissory Note ("Note Agreement") between the Company and York Pharma, plc ("York").
In order to consummate the remittance, on July 22, 2009, the Company entered into a Forbearance Agreement where the Company agreed, in exchange for a payment of $250,000, to forbear for a period of no more than seven days from exercising its rights and remedies under the Note Agreement and certain related loan documents.
The payment received from York was applied first to unpaid interest and then the remainder to reduce the aggregate principal amount owed to the Company. Accordingly, the aggregate principal amount payable to the Company was reduced to $774,246. The Forbearance Agreement provided that the remaining principal would accrue interest at an increased rate of 14% per annum.
On July 24, 2009, the Company assigned all of its interest in and to its rights, benefits and obligations under the Note Agreement to an unrelated third party in exchange for a cash payment of $774,246 plus all accrued but unpaid interest. As a result of such assignment, the Company no longer has any interest in the Loan Documents.
Renaat Van den Hooff, President & CEO of ULURU Inc., commented: "We are very pleased that we've been able to recuperate the amounts owed to our Company. It certainly gives us more breathing room and allows us to focus on the available options for strategic partnerships and continuation of our business plan."|
|Looking back, I think it was making Sadler Entrepreneur of the Year in 2000 that turned his head.
After that it was just one big ego trip.|
and that's a £5k loss...
|WetDream. When you fill out your tax return with CGT particulars you will just put down amount paid for YRK etc and holding and then amount worth when submitted i.e £0 and then accountant if you have one will offset it or tax office if you are going direct through them. Attach a copy RNS if you like to confirm called in administrators etc. Hope that helps.|
|Hey guys, having lost about £5 in YRK how do I go about offsetting these losses for CGT purposes against gains elsewhere, if the shares aren't tradable?
|No I do drink occasionally but modestly. Unfortunately I dont see many fit women walking down the street as Im stuck to my desk in my office Mon-Fri and my house overlooks a graveyard and theres no fit women in there.!!!|
|And i dont drink and look at fit women walking down the street :-))|
|Oh and by the way I never lie.!!!|
|8Trade. Im chilled mate, I have no problem with your post but I dont expect a CEO of a listed company to feed myself and others with a load of bullsh*t about what is going on behind the scenes, he should of actually said nothing instead of lying and getting folks hopes up of ever seeing any of their money again. Anyway time to move on from this one, yet another share certificate to donate to charity.!!!|
|I remember buying in at around a £1 and checking for an rns everyday re abasol
alas it never arrived
|The end of YRK. It took a while, but unfortunately this looked inevitable. Sadler made the same mistake as Bioglan and borrowed, even though he said he wouldn't make the same error again! We never heard about Abasol did we. Some high profile investors lost their shirt on this. I managed to break-even which is better than most. Had no shares left at the end. We've all learnt a lesson on this one though. Bioshark was correct. I'd love to know the truth on Abasol formally, but guess we will never know unless the administrators report (issued in a month or two normally) tells the real story!|
Really sorry you have lost money on this one
Did say only last week your money had gone
A bit like mine has in CTT
Thats the stock market for you
Chin up buddy|
|and the rest of the YRK (mis)management.|